Vericel (VCEL) Total Debt Growth (3y) (2013 - 2018)
Vericel (VCEL) Total Debt Growth (3y) (2013 - 2018) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Vericel |
2.04 Bn |
1.90 Bn |
49.27 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2018 |
445.98% |
| Jun 30, 2018 |
474.60% |
| Mar 31, 2018 |
456.63% |
| Dec 31, 2017 |
239.62% |
| Sep 30, 2017 |
284.08% |
| Jun 30, 2017 |
48.87% |
| Mar 31, 2017 |
1,617.07% |
| Dec 31, 2016 |
413.20% |
| Sep 30, 2016 |
312.13% |
| Jun 30, 2016 |
39.88% |
| Mar 31, 2016 |
28.82% |
| Dec 31, 2015 |
21.08% |
| Sep 30, 2015 |
18.24% |
| Jun 30, 2015 |
15.54% |
| Mar 31, 2015 |
13.17% |
| Dec 31, 2014 |
78.76% |
| Sep 30, 2014 |
15.23% |
| Jun 30, 2014 |
157.75% |
| Dec 31, 2013 |
-71.34% |
